RecruitingPhase 3NCT06801834
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Sponsor: Gilead Sciences
Abilene, TX · Houston, TX · New Braunfels, TX · +20 more sites